Clinical Trial Update: Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating lenvatinib in combination with cetuximab in patients with advanced head and neck squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED